Polyvinyl Alcohol Hydrogel Hemiarthroplasty of First Metatarsophalangeal Joint Hallux Rigidus

Albert T Anastasio; Aman Chopra; Naji M Madi; Troy Q Tabarestani; Amanda N Fletcher; Selene G Parekh

doi:10.7759/cureus.58583

Polyvinyl Alcohol Hydrogel Hemiarthroplasty of First Metatarsophalangeal Joint Hallux Rigidus

Cureus. 2024 Apr 19;16(4):e58583. doi: 10.7759/cureus.58583. eCollection 2024 Apr.

Authors

Albert T Anastasio¹, Aman Chopra², Naji M Madi¹, Troy Q Tabarestani³, Amanda N Fletcher¹, Selene G Parekh⁴

Affiliations

¹ Department of Orthopedic Surgery, Duke University Medical Center, Durham, USA.
² Department of Orthopedic Surgery, Georgetown University School of Medicine, Washington, DC, USA.
³ Department of Neurosurgery, Duke University School of Medicine, Durham, USA.
⁴ Department of Orthopaedic Surgery, Rothman Orthopaedic Institute, Philadephia, USA.

Abstract

Background Hallux rigidus (HR) is the most common arthritic condition of the foot. Although first metatarsophalangeal joint (MTPJ) arthrodesis has been the historical gold-standard treatment, polyvinyl alcohol (PVA) hydrogel implants have gained popularity as a joint-sparing technique. However, recent studies have shown variable failure rates of PVA hydrogel implants. The purpose of this study was to report the five-year experience with PVA hydrogel implants performed by a single surgeon. Methodology Health records were queried from August 2016 to 2021 for patients who underwent primary PVA hydrogel implant hemiarthroplasty for symptomatic late-stage HR. Patient demographics and postoperative outcomes variables were evaluated. Kaplan-Meier analysis was used to evaluate implant survival. A total of 146 PVA hydrogel implant procedures were performed with a minimum six-month follow-up. Results The majority of patients were female (n = 103, 70.5%), with a mean age of 58.1 (±10.1) years, body mass index of 27.3 (±5.2) kg/m², and American Society of Anesthesiologists score <3 (n = 131, 89.7%). The majority had stage II or III disease (n = 115, 78.8%). Patients experienced significant improvement in visual analog scale score (p < 0.0001) and hallux dorsiflexion (p = 0.0005). There were 22 (15.1%) complications, including implant subsidence (n = 15, 10.3%), deep infection (n = 6, 4.1%), and hypertrophic ossification (n = 1, 0.7%). Revision surgeries were required in 12.3% (n = 18) of patients at an average of 9.4 (±9.2) months postoperatively. This included nine (6.2%) revision PVA hydrogel implant procedures and nine (6.2%) first MTJP arthrodesis. The one- and two-year survival rates for MTPJ arthrodesis (n = 9) were 95.9% and 86.3%, respectively. Conclusions In the largest single-surgeon series reported, first MTPJ hemiarthroplasty with a PVA hydrogel implant significantly improved pain and hallux dorsiflexion at an average of 14.5 months postoperatively. There was a high two-year survivorship of 86.3% until failure which required first MTPJ arthrodesis. Future studies should be performed to refine the indications for PVA hydrogel implants and identify risk factors.

Keywords: hallux rigidus; hemiarthroplasty; hydrogel implants; metatarsophalangeal joint; polyvinyl alcohol.